Organometallic Compound for Deep Blue OLED Efficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current organic light-emitting devices face limitations in achieving deep blue light emission with high luminescence efficiency and color purity due to challenges in finding materials with suitable electrical characteristics for the emission layer.
Innovation Solution
The development of an organometallic compound represented by Formula 1, which includes a Period 1, 2, or 3 transition metal, is used in the organic layer of an organic light-emitting device. This compound improves luminescence efficiency and is suitable for deep blue light emission by optimizing the highest occupied molecular orbital (HOMO), lowest unoccupied molecular orbital (LUMO), triplet, and singlet energy levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional organic light-emitting materials are used in the emission layer, then the device structure is simple, but the luminescence efficiency and color purity for deep blue light emission are insufficient
Solution Approach 1:
The patent modifies the molecular structure parameters of the organometallic compound by introducing specific ligands (Formula 1-1) with particular substituents (A10, A30, A40, A20, A21, A22) and adjusting the coordination geometry around the transition metal center. This structural parameter optimization enables deep blue light emission with high color purity and luminescence efficiency while maintaining device structure simplicity
Solution Approach 2:
The patent employs composite organometallic compounds combining transition metals (Period 1, 2, or 3) with organic ligands containing specific heterocyclic and carbocyclic groups. This composite material approach achieves both high luminescence efficiency and color purity for deep blue emission, resolving the contradiction between material complexity and performance
2Manufacturing precision
If materials with optimized HOMO, LUMO, triplet, and singlet energy levels are developed, then luminescence efficiency improves, but material development complexity increases
Solution Approach 1:
The patent systematically adjusts energy level parameters by selecting specific transition metals and coordinating them with ligands containing particular heterocyclic groups (pyridine, pyrimidine, triazine) and carbocyclic groups. The energy levels are optimized by modifying substituents (R1, R2, R10, R20-R22, R30, R40) and their positions, achieving deep blue emission with high luminescence efficiency through controlled parameter variation rather than complex material synthesis
Solution Approach 2:
The patent introduces specific functional groups and substituents at particular positions within the ligand structure (A10, A30, A40 representing different regions of the ligand). This local optimization of molecular structure allows precise control over HOMO, LUMO, triplet, and singlet energy levels, achieving high luminescence efficiency without requiring overall material complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The organometallic compound enhances the luminescence efficiency and color purity of deep blue light emission in organic light-emitting devices, achieving low driving voltage, high quantum efficiency, long lifespan, and minimal roll-off.
Implementation Method 1
Holes provided from the anode may move toward the emission layer through the hole transport region, and electrons provided from the cathode may move toward the emission layer through the electron transport region. The holes and the electrons recombine in the emission layer to produce excitons. These excitons transit from an excited state to a ground state, thereby generating light.
Implementation Method 2
luminescent compounds, for example, phosphorescent compounds, may be used for monitoring, sensing, and detecting biological materials such as various cells and proteins
Data Source
AI summary
An organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound are provided:M1(L11)n11(L12)n12 Formula 1wherein, in Formula 1, L11 may be a ligand represented by Formula 1-1, and the other substituents may be understood by referring to the descriptions thereof provided in the detailed description: